{"id":15902,"date":"2020-11-30T09:58:40","date_gmt":"2020-11-30T08:58:40","guid":{"rendered":"https:\/\/idibell.cat\/?p=15902"},"modified":"2020-11-30T11:46:26","modified_gmt":"2020-11-30T10:46:26","slug":"la-marato-financara-10-projectes-de-lidibell-en-malalties-minoritaries-amb-15-milions-deuros","status":"publish","type":"post","link":"https:\/\/idibell.cat\/2020\/11\/la-marato-financara-10-projectes-de-lidibell-en-malalties-minoritaries-amb-15-milions-deuros\/","title":{"rendered":"La Marat\u00f3 finan\u00e7ar\u00e0 10 projectes de l\u2019IDIBELL en malalties minorit\u00e0ries amb 1,5 milions d\u2019euros"},"content":{"rendered":"<p>L\u2019Institut d\u2019Investigaci\u00f3 Biom\u00e8dica de Bellvitge (IDIBELL) ha rebut m\u00e9s d\u20191,5 milions d\u2019euros de La Marat\u00f3 de TV3 i Catalunya R\u00e0dio 2019 per a finan\u00e7ar 10 projectes d\u2019investigaci\u00f3 en malalties minorit\u00e0ries. L\u2019edici\u00f3 de <a href=\"https:\/\/www.ccma.cat\/tv3\/marato\/projectes-financats\/2019\/1930\/\">La Marat\u00f3 de 2019<\/a> ha perm\u00e8s finan\u00e7ar, durant els pr\u00f2xims 3 anys, fins a 41 projectes de recerca biom\u00e8dica d\u2019excel\u00b7l\u00e8ncia per aconseguir proves per detectar aquestes malalties en el moment de n\u00e9ixer, fer disminuir el temps de diagn\u00f2stic i disposar de tractaments eficients, adequats i segurs, amb l\u2019objectiu de millorar la qualitat i l\u2019esperan\u00e7a de vida de les persones que hi conviuen.<\/p>\n<p>En l\u2019edici\u00f3 del 2019 es van presentar 228 projectes que han estat revisats per 190 cient\u00edfics internacionals experts en malalties minorit\u00e0ries. El proc\u00e9s de selecci\u00f3 ha estat coordinat per l\u2019Ag\u00e8ncia de Qualitat i Avaluaci\u00f3 Sanit\u00e0ries de Catalunya i pel Departament de Salut, que han valorat la qualitat, la metodologia, la rellev\u00e0ncia cient\u00edfica, sanit\u00e0ria i social, el valor innovador i la viabilitat.<\/p>\n<p>&nbsp;<\/p>\n<h3>Els projectes de l\u2019IDIBELL de La Marat\u00f3 2019<\/h3>\n<p>&nbsp;<\/p>\n<p>L&#8217;IDIBELL ha estat un dels centres amb m\u00e9s projectes finan\u00e7ats, fins a 10, dels quals en lidera 7, i participa en 3 projectes m\u00e9s com a col\u00b7laborador.<\/p>\n<p>Entre els projectes centrats en la recerca de noves ter\u00e0pies per a les malalties minorit\u00e0ries el <strong>Dr. Francisco Javier Narv\u00e1ez<\/strong> lidera un projecte que pret\u00e9n millorar la classificaci\u00f3 dels pacients amb esclerod\u00e8rmia per tal de tractar millor la malaltia. Per altra banda, l&#8217;equip de la <strong>Dra. Virgina Nunes<\/strong> i l&#8217;equip del <strong>Dr. Miquel Angel Pujana<\/strong> cercaran noves ter\u00e0pies i biomarcadors per la cistin\u00faria, una afecci\u00f3 renal en la qual s&#8217;acumulen pedres de cistina al rony\u00f3 i la bufeta, i la linfangioleiomiomatosi, una malaltia pulmonar poc freq\u00fcent que es caracteritza per la destrucci\u00f3 tissular progressiva d&#8217;aquest \u00f2rgan, respectivament. Per la seva banda, la <strong>Dra. Antonella Consiglio<\/strong> participar\u00e0 en un projecte per desenvolupar tractaments personalitzats en malalties gen\u00e8tiques rares causants de parkinsonisme pedi\u00e0tric.<\/p>\n<p>La recerca de nous biomarcadors que permetin fer un diagn\u00f2stic preco\u00e7 d&#8217;aquest tipus de malalties tamb\u00e9 \u00e9s un aspecte cr\u00edtic per poder abordar-les amb m\u00e9s efic\u00e0cia. L&#8217;equip de <strong>la Dra. Marta Pineda<\/strong> planeja caracteritzar els esdeveniments moleculars inicials de la carcinog\u00e8nesi associada a una s\u00edndrome de predisposici\u00f3 a c\u00e0ncer pedi\u00e0tric (s\u00edndrome de defici\u00e8ncia constitucional de reparaci\u00f3 d\u2019errors d\u2019aparellament), per millorar-ne el seguiment i prevenci\u00f3. Paral\u00b7lelament, la <strong>Dra. Alessandra Giorgetti<\/strong> participar\u00e0 en un projecte que buscar\u00e0 noves estrat\u00e8gies per a identificar marcadors gen\u00e8tics d&#8217;un tipus de leuc\u00e8mia infantil heredit\u00e0ria. Finalment, l&#8217;equip de la <strong>Dra. Ariadna Padr\u00f3<\/strong> formar\u00e0 part d&#8217;una xarxa interhospital\u00e0ria catalana que estudiar\u00e0 variants gen\u00e8tiques per a la detecci\u00f3 de malalties minorit\u00e0ries.<\/p>\n<p>Aix\u00ed mateix, l&#8217;equip del <strong>Dr. Carlos Casasnovas<\/strong> buscar\u00e0 noves causes gen\u00e8tiques de trastorns de moviment hereditaris. Per la seva banda, la <strong>Dra. Barbara Rivera<\/strong> estudiar\u00e0 el mecanisme pel qual els defectes hereditaris de la maquin\u00e0ria de producci\u00f3 d\u2019ARN regulador causen n\u00f2duls indolents i c\u00e0ncers agressius de tiroides, el qu\u00e8 ajudar\u00e0 a la classificaci\u00f3 i tractament de pacients en risc. I per acabar, el <strong>Dr. Joan Torras<\/strong> intentar\u00e0 desxifrar els mecanismes d&#8217;autoimmunitat de la nefropatia membranosa prim\u00e0ria, una afecci\u00f3 renal que comporta l&#8217;engrossiment de la membrana basal dels capil\u00b7lars del glom\u00e8rul el que comporta una mala filtraci\u00f3 de les prote\u00efnes.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>L&#8217;IDIBELL ha estat un dels centres amb m\u00e9s projectes finan\u00e7ats, fins a 10, dels quals en lidera 7, i participa en 3 projectes m\u00e9s com a col\u00b7laborador.<\/p>\n","protected":false},"author":8,"featured_media":15903,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"site-sidebar-layout":"default","site-content-layout":"default","ast-site-content-layout":"","site-content-style":"default","site-sidebar-style":"default","ast-global-header-display":"","ast-banner-title-visibility":"","ast-main-header-display":"","ast-hfb-above-header-display":"","ast-hfb-below-header-display":"","ast-hfb-mobile-header-display":"","site-post-title":"","ast-breadcrumbs-content":"","ast-featured-img":"","footer-sml-layout":"","theme-transparent-header-meta":"default","adv-header-id-meta":"","stick-header-meta":"default","header-above-stick-meta":"","header-main-stick-meta":"","header-below-stick-meta":"","astra-migrate-meta-layouts":"default","ast-page-background-enabled":"default","ast-page-background-meta":{"desktop":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"ast-content-background-meta":{"desktop":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"footnotes":""},"categories":[488,332,390,417,353,475,396,468,380,349,334,339,340,464,466,479,447,482,457,469,452],"tags":[],"class_list":["post-15902","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-biologia-de-cellules-mare-hematopoetiques-i-leucemogenesi","category-cancer","category-cancer-de-mama","category-cancer-hereditari-noticies","category-cellules-mare-i-malalties-neurodegeneratives","category-farmacoterapia-i-tecnologia-farmaceutica","category-genetica-molecular-humana","category-inflamacio-sinovial-i-metabolisme-ossi","category-malalties-neurometaboliques","category-medicina-regenerativa","category-medicina-translacional","category-nefrologia-i-transplantament-renal","category-neurociencies","category-p-de-gens-malaltia-i-terapia","category-p-de-malalties-cardiovasculars-respiratories-sistemiques-i-denvelliment-cellular","category-p-de-malalties-infeccioses-i-transplantaments","category-p-de-mecanismes-molelculars-i-terapia-experimental-en-oncologia-oncobell","category-p-de-medicina-regenerativa","category-p-de-neurociencies","category-p-de-sistema-digestiu-diagnostic-farmacogenetica-infermeria-i-prevencio-clinica","category-procure"],"publishpress_future_action":{"enabled":false,"date":"2025-01-31 04:36:13","action":"change-status","newStatus":"draft","terms":[],"taxonomy":"category"},"publishpress_future_workflow_manual_trigger":{"enabledWorkflows":[]},"_links":{"self":[{"href":"https:\/\/idibell.cat\/wp-json\/wp\/v2\/posts\/15902","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/idibell.cat\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/idibell.cat\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/idibell.cat\/wp-json\/wp\/v2\/users\/8"}],"replies":[{"embeddable":true,"href":"https:\/\/idibell.cat\/wp-json\/wp\/v2\/comments?post=15902"}],"version-history":[{"count":0,"href":"https:\/\/idibell.cat\/wp-json\/wp\/v2\/posts\/15902\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/idibell.cat\/wp-json\/wp\/v2\/media\/15903"}],"wp:attachment":[{"href":"https:\/\/idibell.cat\/wp-json\/wp\/v2\/media?parent=15902"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/idibell.cat\/wp-json\/wp\/v2\/categories?post=15902"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/idibell.cat\/wp-json\/wp\/v2\/tags?post=15902"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}